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Abstract Pseudomonas aeruginosa cytotoxin (CTX) is thought to be a pore-forming polypeptide of 29 kDa. To study whether CTX assembles into 
oligomer on target membranes, we solubilized membrane-bound toxin with 1% sodium dodecyl sulfate (SDS) at 25’C and analyzed its molecular 
size using SDS-polyacrylamide gel electrophoresis and immunoblot analysis. The results indicate that CTX forms a complex of approximately 145 
kDa on the surface of erythrocytes and lipid vesicles, and that the complex formation is closely correlated with the toxin-induced permeabilization 
of target membranes. Thus, CTX may assemble into a pore-forming oligomer on target membranes. 
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1. Introduction 
Pseudomonas aeruginosa is a Gram negative opportunistic 
pathogen which infects compromised and immunosuppressed 
hosts [l]. Although molecular pathogenesis of P aeruginosa 
infection is still a controversial issue, several toxic products of 
the bacterium have been identified as possible virulence factors 
[2, 31. E! aeruginosa cytotoxin (CTX) is a 29 kDa polypeptide 
endowed with lethal activity to mice and cytolytic activity to- 
wards leukocytes and other types of cells [4-61. We have previ- 
ously shown that CTX is produced as a 31-kDa cell-associated 
precursor (proCTX), which is converted into a 29-kDa active 
toxin by the proteolytic removal of 20 amino acid residues from 
the C-terminus of proCTX [7]. Recently, the CTX gene was 
found to be carried by a temperate phage of P aeruginosa [S]. 
CTX is thought to be a member of pore-forming toxins, 
because CTX induces selective leakage of low molecular sub- 
stances from target cells [9-l I] and because it forms ion channel 
in planar lipid membranes [12]. Functional diameter of the 
membrane pore formed by CTX was estimated to be 2.4 nm by 
the experiments involving the use of osmotic protectants with 
different hydrodynamic diameters [121. However, the molecular 
architecture of its membrane pore remains to be elucidated. In 
this paper, we analyzed the membrane-bound states of CTX to 
clarify whether or not CTX forms oligomers on the target 
membranes. 
2. Materials and methods 
2.1. Chemicals 
Carboxylhtorescein (CF) was purchased from Eastman Kodak 
(Rochester, NY), and purified as described by Weinstein et al. [13]. 
Azolectin (L-a-phosphatidylcholine type II-S from soybean) and 
cholesterol were from Sigma (ST. Louis, MO). Alkaline phosphatase- 
conjugated anti rabbit immunoglobulins erum was obtained from 
Promega (Madison, WI). 
2.2. CTX 
Active CTX was purified from the trypsin-treated crude extract of 
*Corresponding author. Fax: (81) (263) 34 0176. 
tl aeruginosa PA158 as described previously [6]. Protein concentration 
was determined by the method of Lowry [14]. 
2.3. Determination of hemolytic activity 
A standard titration was performed as follows: erythrocyte suspen- 
sion (6.5%, v/v; 5 ~1) was incubated with CTX solution (45 ~1) in 
Dulbecco’s phosphate-buffered saline (PBS), pH 7.5, at 37°C. After a 
given incubation period, ice-cold PBS (950~1) was added to the mixture 
and centrifuged at 15,000 x g for 10 min at 4°C. The supematant was 
assayed spectrophotometrically for hemoglobin at 412 nm. Osmotic 
lysis of erythrocytes in distilled water was taken as 100% hemolysis. For 
estimation of CTX-mediated hemolysis at different pH, erythrocytes 
were incubated with CTX in 50 mM phosphate buffer, pH 68, contain- 
ing 0.65% sodium chloride. Erythrocytes were not lyzed without CTX 
in this pH range. 
2.4. Multilamellar liposomes and CTX-mediated leakage of an internal 
marker from the liposomes 
Multilamellar liposomes were prepared from total lipids of monkey 
erythrocyte membrane or azolectin (L-a-phosphatidylcholine type II-S 
from soybean; Sigma chemical) and cholesterol (8: 1; w/w) as described 
previously [15]. Total lipids of monkey erythrocyte membrane were 
extracted as described by Bligh and Dyer [16]. To assess CTX-mediated 
leakage of an internal marker from liposomes, 45 ~1 of serial dilutions 
of CTX were incubated with 5 ~1 of carboxyfluorescein (CF)-loaded 
liposomes at 37°C for 60 min. Fluorescence intensity was measured 
with a Hitachi fluorometer F3000 (Niseisangyo, Co., Tokyo) with an 
exitation at 490 nm and an emmision at 530 nm. Hundred percent of 
CF leakage was defined as the fluorescence intensity obtained upon 
exposure of liposomes to 0.5% Triton X-100 at 37’C for 60 min. 
2.5. Oligomer formation of CTX on the surface of target membranes 
After incubation of erythrocyte or liposome suspension (5 ~1) with 
CTX solution (45 ~1) at 37°C for indicated time period, erythrocyte- 
bound or liposome-bound CTX was collected by centrifugation at 
15,000 x g for 5 min at 4°C and washed by subsequent centrifugation 
to remove residual unbound toxin. The membrane-bound toxin was 
solubilized at 25°C for 10 min with sodium dodecyl sulfate-poly- 
acrylamide gel electrophoresis (SDS-PAGE) loading buffer (50 ~1) con- 
taining 1% SDS and 2.5% 2-mercaptoethanol. The solubilized CTX 
(10~1) was subjected to SDS-PAGE using a 415% gradient gel of 
acrylamide. SDS-PAGE was performed according to the method of 
Laemmli [17], except for omission of the heating of the solubilized CTX 
at 100°C. For immunoblot analysis, proteins in the gel were electro- 
phoretically transferred onto a nitrocellulose filter by the method of 
Towbin et al. [18]. After blocking with skim milk, the filter was incu- 
bated with diluted anti-CTX serum of rabbit, followed by incubation 
with a dilution of alkaline phosphatase-conjugated anti rabbit immu- 
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noglobulins serum. Color development was performed using nitroblue 
tetrazolium and 5-bromo-4-chloro-3-indolyl phosphate. The nitrocellu- 
lose filter was subjected to densitometry for determination of complex 
formation. Percent complex formation was defined as follows: (area of 
oligomer/area of monomer and oligomer) x 100. Anti CTX serum was 
prepared as previously described [6]. 
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3. Results and discussion 
Several pore-forming toxins have been demonstrated to form 
high-molecular-weight complexes on target cells, and the com- 
plex formation of these toxins seems to be a common key event 
in the process of intoxication [19]. To study whether CTX forms 
a high-molecular-weight complex on target membranes, mem- 
brane-bound CTX was solubilized with the SDS-PAGE load- 
ing buffer at 25°C for 10 min and subjected to SDS-PAGE 
followed by immunoblotting as described in section 2. An im- 
munostained band corresponding to approximately 145 kDa 
were detected together with the 29-kDa band of monomeric 
CTX, when rat erythrocytes were incubated with CTX (20 
pg/ml) at 37’C for 60 min (Fig. 1, lane 2; CTX induced 100% 
hemolysis under these conditions, see Fig. 2A). However, 
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Fig. 1. Complex formation of CTX on the surface of rat erythrocytes. 
Rat erythrocytes were incubated with CTX (20 &ml; lane 2) or heat 
inactivated CTX (20 PgIml; lane 3) at 37°C for 60 min. After the 
incubation, membrane-bound CTX was solubilized and subjected to 
SDS-PAGE followed by immunoblotting using anti-CTX antiserum as 
described in section 2. Heat-inactivated CTX was obtained by heating 
of CTX at 70°C for 10 min. As references, CTX (50 ng; lane 1) or rat 
erythrocytes (lane 4) were solubilized and subjected to SDS-PAGE and 
immunoblotting. 
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Fig. 2. Correlation between hemolytic activity and complex formation of CTX. (A) Hemolytic activity of CTX towards the erythrocytes of different 
animals: rat (0), rabbit (0) and human (m) erythrocytes were incubated with CTX at 37°C for 60 min. (B) Complex formation of CTX on rat, rabbit 
and human erythrocytes: CTX (20 &ml) was incubated with the erythrocytes under similar conditions to (A). (C) Kinetics of the CTX-induced 
hemolysis at different temperatures: rat erythroctyes, which have been previously exposed to CTX (10 @ml) at 4°C for 30 min, were incubated at 
15°C (*), 20°C (0), 25°C (o), 30°C (@ or 37°C (0) for the indicated time periods. (D) Temperature ffect on the complex formation of CTX: complex 
formation was assayed after I-min incubation of rat erythrocytes with CTX (10 &ml) at different temperatures. (E) Hemolytic activity of CTX at 
different extracellular pH values: rat erythrocytes were incubated with CTX at 37°C for 60 min in 50 mM phosphate buffer, pH 6.0 (+), 6.4 (o), 
6.8 (m). 7.2 (0), 7.6 (0) or 8.0 (III). (F) Effect of extracellular pH on the complex formation of CTX: rat erythrocytes were incubated with CTX 
(2.5 &ml) at 37°C for 60 min at different pH values. Hemolytic and complex-forming activities of CTX were assayed as described in section 2. Mean 
values of % hemolysis were obtained from three independent experiments. Percent complex formation was calculated as described in section 2. 
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Fig. 3. Assembly of CTX on the liposomes prepared from total lipids 
of erythrocyte membranes (A) and leakage of an internal marker from 
the vesicle (B). (A) Multilamellar liposomes prepared from total lipids 
of monkey erythyrocyte membrane were incubated with CTX (25-200 
pug/ml) at 37°C for 60 min. Membrane-bound toxin was solubilized and 
subjected to SDS-PAGE, followed by immunoblotting using anti-CTX 
serum as described in section 2. The arrowhead indicates the position 
of the 145-kDa band of a CTX ollgomer. MW, molecular weights. (B) 
Carboxvfluorescein (CF)-loaded liuosomes of the same liuid comuosi- 
tion were incubated with various d&s of CTX at 37°C for 60 min. CF 
leakage was assayed as described in section 2. Mean values from three 
independent experiments were plotted. 
the 145-kDa band was not stained when heat-inactivated CTX 
was used (Fig. 1, lane 3). No intrinsic membrane protein of 
the erythrocyte was inununostained with the anti-CTX serum 
(Fig. 1, lane 4). These results suggest that CTX forms a complex 
of approximately 145 kDa on rat erythrocytes when it causes 
hemolysis. 
To examine the relationship between CTX-induced hemoly- 
sis and complex formation of the toxin, we assayed hemolytic 
and complex-forming activities of CTX under various condi- 
tions. CTX caused 50% lysis of rat, rabbit and human erythro- 
cytes at 6.3, 27 and >400 lug/ml, respectively (Fig. 2A). When 
a toxin concentration of 20 ,@ml was employed, CTX lyzed 
100 and 30% of rat and rabbit erythrocytes, respectively 
(Fig. 2A). CTX (20 pg/ml) formed the innnunostained band of 
145 kDa under these conditions, and% complex formation of 
CTX increased in proportion to the toxin-induced hemolysis 
(Fig. 2B). In contrast, CTX caused neither hemolysis nor for- 
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mation of the 145-kDa band when the toxin was incubated with 
human erythrocytes under the same conditions. 
Effect of incubation temperature on hemolytic and complex- 
forming activities of CTX was investigated. Rat erythrocytes 
were preincubated with CTX (10 &ml) at 4°C for 30 min, 
followed by incubation at a temperature of between 15 and 
37°C. CTX lyzed the erythrocytes at the temperatures above 
20°C and the CTX-induced hemolysis occurred more rapidly 
as the incubation temperature was raised (Fig. 2C). Complex 
formation was assayed after 1-min incubation of the erythro- 
cytes with CTX (10 pg/ml) at different temperatures. The re- 
sults indicate that CTX formed the 145-kDa complex at 25“C 
or above, and that the complex formation occurred more effi- 
ciently at higher temperatures (Fig. 2D). Thus, complex forma- 
tion of CTX is a temperature-dependent process, which takes 
place in parallel with hemolysis. Membrane fluidity of erythro- 
cytes may play a crucial role for the complex formation of CTX 
on the surface of erythrocyte, because previous studies using 
Raman spectroscopy and fluorescence photobleaching have de- 
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Fig. 4. Oligomerizahon of L IX on me nposomes composeo r azotectin 
and cholesterol (A) and permeabilization of the membrane (B). (A) 
Lanes 14 the liposomes composed ofazolectin and cholesterol were 
incubated with CTX (50, 100,200 and 400 &ml, respectively) at 37°C 
for 60 min. Lane 5: as reference, rat erythrocytes were incubated with 
CTX (20 &ml) at 37°C for 60 min. (B) Carboxyfluorescein (CF)- 
loaded liposomes of the same lipid composition were exposed to various 
dosed of CTX at 37°C for 60 min. Oligomerization of CTX and CF 
leakage were assayed as described in section 2. The arrowhead repre- 
sents the position of the CTX oligomer of 145 kDa. 
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tected moderate thermotrophic phase transition of erythrocyte 
membrane at a temperature of between 15 and 22°C [20,21]. 
Xiong et al. reported that cytolytic activity of CTX is en- 
hanced at lower pH, although binding of the toxin is pH- 
independent [22]. Therefore, we studied the effect of extracellu- 
lar pH on hemolytic and complex-forming activities of CTX. 
CTX (2.5 @ml) formed the 145kDa complex at pH 6.0 
through to pH 7.2 where it induced hemolysis, and intensity of 
the 145-kDa band increased as the extracellular pH was low- 
ered in this pH range (Fig. 2F). Neither complex formation of 
CTX nor toxin-induced hemolysis was detected at pH 7.6 and 
8.0, although CTX bound to the erythrocytes under these con- 
ditions (Fig. 2F). 
Thus, complex formation of CTX on the cell surface was 
closely correlated with the toxin-induced hemolysis under vari- 
ous conditions, suggesting that the complex formation is a 
prerequisite for the pore-forming activity of CTX. The im- 
munostained band of 145 kDa appeared to correspond to a 
pentameric form of CTX on the basis of the molecular size. 
However, there remained a possibility that the CTX complex 
includes intrinsic membrane protein(s) of erythrocytes. To test 
this possibility, we assayed complex formation of CTX on lipid 
vesicles. Multilamellar liposomes were prepared from total lip- 
ids of monkey erythrocyte membrane, because monkey eryth- 
rocytes were more susceptible to CTX than the erythrocytes of 
other animals so far tested (i.e. the CTX concentration required 
to induce 50% lysis of monkey erythrocytes was 3.6 pglml). As 
shown in Fig. 3A, an immunostained band of 145 kDa was 
formed in a dose-dependent manner when the liposomes were 
incubated with CTX. CTX also caused a concentration-de- 
pendent leakage of carboxyfluorescein, as an internal marker, 
from the vesicles (Fig. 3B), although permeabilization of the 
membrane needed much more toxin than hemolysis of monkey 
erythrocytes. Similar results were obtained using the liposomes 
composed of azolectin (L-a-phosphatidylcholine type II-S from 
soybean) and cholesterol as another lipid membrane (Fig. 
4A,B). These results indicate that the immunostained band of 
145 kDa corresponds to an oligomeric CTX, probably a pen- 
tameric form of the toxin. Thus, it is likely that CTX assembles 
into a pore-forming pentamer on the surface of target mem- 
branes. Recently Lutz et al. reported that a CTX-binding pro- 
tein exists on the surface of rabbit erythrocytes [23]. At the 
present time, however, it is not clear whether such a CTX- 
binding protein is involved in the assembly process of CTX on 
the cell surface. 
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